European Journal of Haematology, 1600-0609

Journal

More filtering options
  1. 2019
  2. Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication, and strategies for difficult-to-treat patients

    Rolf Ljung, Auerswald, G., Benson, G., Dolan, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Lambert, T., Morfini, M., Zupančić-Šalek, S. & Santagostino, E., 2019 Feb, In : European Journal of Haematology. 102, 2, p. 111-122

    Research output: Contribution to journalReview article

  3. 2018
  4. Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival

    Ingemar Turesson, Bjorkholm, M., Blimark, C. H., Kristinsson, S., Velez, R. & Landgren, O., 2018 Aug 1, In : European Journal of Haematology. 101, 2, p. 237-244 8 p.

    Research output: Contribution to journalReview article

  5. Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - A Swedish nationwide cohort study

    Vaht, K., Göransson, M., Carlson, K., Isaksson, C., Lenhoff, S., Sandstedt, A., Uggla, B., Winiarski, J., Ljungman, P., Brune, M. & Andersson, P. O., 2018, In : European Journal of Haematology. 100, 6, p. 613-620

    Research output: Contribution to journalArticle

  6. 2017
  7. Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis

    Moreau, P., Dimopoulos, M. A., Richardson, P. G., Siegel, D. S., Cavo, M., Corradini, P., Weisel, K. C., Delforge, M., O'Gorman, P., Song, K., Chen, C., Bahlis, N., Oriol, A., Hansson, M., Kaiser, M., Anttila, P., Raymakers, R., Joao, C., Cook, G., Sternas, L. & 7 othersBiyukov, T., Slaughter, A., Hong, K., Herring, J., Yu, X., Zaki, M. H. & San Miguel, J., 2017 Sep 1, In : European Journal of Haematology. 99, 3, p. 199-206 8 p.

    Research output: Contribution to journalArticle

  8. Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

    Nahi, H., Genell, A., Wålinder, G., Uttervall, K., Gunnar Juliusson, Karin, F., Markus Hansson, Svensson, R., Linder, O., Carlson, K., Björkstrand, B., Kristinsson, S. Y., Mellqvist, U-H., Blimark, C. & Ingemar Turesson, 2017 Sep, In : European Journal of Haematology. 99, 3, p. 216-222

    Research output: Contribution to journalArticle

  9. Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden

    Kozlowski, P., Lennmyr, E., Ahlberg, L., Bernell, P., Hulegårdh, E., Karbach, H., Karlsson, K., Tomaszewska-Toporska, B., Åström, M., Hallböök, H. & the Swedish Adult Acute Lymphoblastic Leukemia Group (SVALL), 2017 Aug 1, In : European Journal of Haematology. 99, 2, p. 141-149 9 p.

    Research output: Contribution to journalArticle

  10. Outcome measures for adult and pediatric hemophilia patients with inhibitors

    Hermans, C., Auerswald, G., Benson, G., Dolan, G., Duffy, A., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Lambert, T., Mehdi Osooli & Zupančić Šalek, S., 2017 Aug 1, In : European Journal of Haematology. 99, 2, p. 103-111 9 p.

    Research output: Contribution to journalReview article

  11. Genomewide association study on monoclonal gammopathy of unknown significance (MGUS)

    Hauke Thomsen, Campo, C., Weinhold, N., da Silva Filho, M. I., Pour, L., Gregora, E., Vodicka, P., Vodickova, L., Hoffmann, P., Nöthen, M. M., Jöckel, K-H., Langer, C., Hajek, R., Goldschmidt, H., Kari Hemminki & Asta Försti, 2017 Jul, In : European Journal of Haematology. 99, 1, p. 70-79 10 p.

    Research output: Contribution to journalArticle

  12. The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany

    Berntorp, E., Dargaud, Y., Hart, D. P., Lobet, S., Mancuso, M. E., d'Oiron, R., Perry, D., Pollard, D., van den Berg, M., Blatný, J., Chambost, H., Doria, A. S., Holme, P. A., Kaczmarek, R., Mantovani, L., McLaughlin, P., Nanayakkara, L., Petrini, P., Sannié, T., Laane, E. & 6 othersMaia, R., Dettoraki, A., Farrell, A., Halimeh, S., Raza, S. & Taylor, S., 2017 Jan 1, In : European Journal of Haematology. 98, s85, p. 1-15 15 p.

    Research output: Contribution to journalArticle

  13. Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register

    Söderlund, S., Dahlén, T., Sandin, F., Olsson-Strömberg, U., Creignou, M., Dreimane, A., Lübking, A., Markevärn, B., Själander, A., Wadenvik, H., Stenke, L., Johan Richter & Höglund, M., 2017 Jan, In : European Journal of Haematology. 98, 1, p. 57-66

    Research output: Contribution to journalArticle

  14. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing

    Malmberg, E. B. R., Ståhlman, S., Rehammar, A., Samuelsson, T., Alm, S. J., Kristiansson, E., Abrahamsson, J., Garelius, H., Louise Pettersson, Mats Ehinger, Palmqvist, L. & Fogelstrand, L., 2017 Jan, In : European Journal of Haematology. 98, 1, p. 26-37

    Research output: Contribution to journalArticle

  15. Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry

    Lj Lazarevic, V., Aldana Rosso, Gunnar Juliusson, Antunovic, P., Derolf, Å. R., Deneberg, S., Möllgård, L., Uggla, B., Wennström, L., Wahlin, A., Höglund, M., Lehmann, S. & Bertil Johansson, 2017, In : European Journal of Haematology. 98, 5, p. 493-500

    Research output: Contribution to journalArticle

  16. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib

    Niklas Landberg, Dreimane, A., Rissler, M., Billström, R. & Helena Ågerstam, 2017, In : European Journal of Haematology. 99, 5, p. 442-448 7 p.

    Research output: Contribution to journalArticle

  17. The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia

    Larfors, G., Sandin, F., Johan Richter, Själander, A., Stenke, L., Lambe, M. & Höglund, M., 2017, In : European Journal of Haematology. 98, 4, p. 398-406 9 p.

    Research output: Contribution to journalArticle

  18. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery

    Miesbach, W. & Erik Berntorp, 2017, In : European Journal of Haematology. 98, 2, p. 121-127

    Research output: Contribution to journalArticle

  19. 2016
  20. Partnering to change the world for people with haemophilia: 6th Haemophilia Global Summit, Prague, Czech Republic, 24–26th September 2015

    Jan Astermark, Hart, D., Lobet, S., Blatný, J., d'Oiron, R., Kenet, G., Dolan, G., Libotte, V. & Hermans, C., 2016 Jul 1, In : European Journal of Haematology. 97, p. 3-23 21 p.

    Research output: Contribution to journalPublished meeting abstract

  21. The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands

    Erik Berntorp, Hart, D., Mancuso, M. E., d'Oiron, R., Perry, D., O'Mahony, B., Kaczmarek, R., Crato, M., Pasi, J., Miners, A., Katarina Steen Carlsson, Kitchen, S., Boehlen, F., Giangrande, P., Cebura, E., Uitslager, N., Mehdi Osooli, Janeckova, D., Haldon, R. & Rivolta, G. F., 2016 Jul 1, In : European Journal of Haematology. 97, p. 3-18 16 p.

    Research output: Contribution to journalArticle

  22. Enteric-coated mycophenolate sodium could be an alternative to methotrexate for GVHD prophylaxis.

    Lazarevic, V., 2016, In : European Journal of Haematology. 97, 3, p. 213-214

    Research output: Contribution to journalDebate/Note/Editorial

  23. Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.

    Gunnarsson, N., Sandin, F., Höglund, M., Stenke, L., Björkholm, M., Lambe, M., Olsson-Strömberg, U., Johan Richter & Själander, A., 2016, In : European Journal of Haematology. 97, 4, p. 387-392

    Research output: Contribution to journalArticle

  24. 2015
  25. Comorbidities and inhibitors in adult patients with haemophilia: issues, costs and management strategies.

    Erik Berntorp, Mauser-Bunschoten, E., Jiménez-Yuste, V. & Spears, J. B., 2015, In : European Journal of Haematology. 95, p. 1-15

    Research output: Contribution to journalReview article

  26. Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)

    Hjorth-Hansen, H., Stenke, L., Soderlund, S., Dreimane, A., Hans Ehrencrona, Gedde-Dahl, T., Gjertsen, B. T., Hoglund, M., Koskenvesa, P., Lotfi, K., Majeed, W., Markevarn, B., Ohm, L., Olsson-Stromberg, U., Remes, K., Suominen, M., Simonsson, B., Porkka, K., Mustjoki, S. & Johan Richter, 2015, In : European Journal of Haematology. 94, 3, p. 243-250

    Research output: Contribution to journalArticle

  27. Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.

    Lazarevic, V., Hörstedt, A., Bertil Johansson, Antunovic, P., Billström, R., Derolf, A., Lehmann, S., Möllgård, L., Peterson, S., Stockelberg, D., Uggla, B., Vennström, L., Wahlin, A., Höglund, M. & Gunnar Juliusson, 2015, In : European Journal of Haematology. 94, 5, p. 419-423

    Research output: Contribution to journalArticle

  28. Genetic risk factors for inhibitors in haemophilia A

    Bardi, E. & Jan Astermark, 2015, In : European Journal of Haematology. 94, p. 7-10

    Research output: Contribution to journalReview article

  29. Interaction between VWF and FVIII in treating VWD

    Miesbach, W. & Erik Berntorp, 2015, In : European Journal of Haematology. 95, 5, p. 449-454

    Research output: Contribution to journalArticle

  30. Introduction.

    Erik Berntorp, 2015, In : European Journal of Haematology. 94, p. 1-1

    Research output: Contribution to journalDebate/Note/Editorial

  31. Non-genetic risk factors and their influence on the management of patients in the clinic

    Alvarez, T., Soto, I. & Jan Astermark, 2015, In : European Journal of Haematology. 94, p. 2-6

    Research output: Contribution to journalReview article

  32. One-stage vs. chromogenic assays in haemophilia A

    Potgieter, J. J., Damgaard, M. & Andreas Hillarp, 2015, In : European Journal of Haematology. 94, p. 38-44

    Research output: Contribution to journalReview article

  33. Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events

    de Raucourt, E., Roussel-Robert, V. & Eva Zetterberg, 2015, In : European Journal of Haematology. 94, p. 23-29

    Research output: Contribution to journalReview article

  34. Strategies for reducing inhibitor formation in severe haemophilia

    Tunstall, O. & Jan Astermark, 2015, In : European Journal of Haematology. 94, p. 45-50

    Research output: Contribution to journalReview article

  35. Switching treatments in haemophilia: is there a risk of inhibitor development?

    Santagostino, E., Auerswald, G., Benson, G., Dolan, G., Jimenez-Yuste, V., Lambert, T., Rolf Ljung, Morfini, M., Remor, E. & Salek, S. Z., 2015, In : European Journal of Haematology. 94, 4, p. 284-289

    Research output: Contribution to journalReview article

  36. The ageing patient with haemophilia

    Canaro, M., Goranova-Marinova, V. & Erik Berntorp, 2015, In : European Journal of Haematology. 94, p. 17-22

    Research output: Contribution to journalReview article

  37. Various regimens for prophylactic treatment of patients with haemophilia

    Schwarz, R., Rolf Ljung & Ulf Tedgård, 2015, In : European Journal of Haematology. 94, p. 11-16

    Research output: Contribution to journalReview article

  38. 2014
  39. Angiogenesis is increased in advanced haemophilic joint disease and characterized by normal pericyte coverage.

    Eva Zetterberg, Palmblad, J., Wallensten, R., Morfini, M., Melchiorre, D. & Holmström, E. M., 2014, In : European Journal of Haematology. 92, 3, p. 256-262

    Research output: Contribution to journalArticle

  40. High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden

    Kozlowski, P., Astrom, M., Ahlberg, L., Bernell, P., Hulegardh, E., Hagglund, H., Karlsson, K., Markuszewska-Kuczymska, A., Tomaszewska-Toporska, B., Smedmyr, B., Amini, R-M. & Hallbook, H., 2014, In : European Journal of Haematology. 92, 5, p. 377-381

    Research output: Contribution to journalArticle

  41. Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review

    Laros-van Gorkom, B. A. P., Falaise, C. & Jan Astermark, 2014, In : European Journal of Haematology. 93, p. 26-38

    Research output: Contribution to journalReview article

  42. Methods for individualising factor VIII dosing in prophylaxis

    Ar, M. C., Vaide, I., Erik Berntorp & Bjorkman, S., 2014, In : European Journal of Haematology. 93, p. 16-20

    Research output: Contribution to journalReview article

  43. On-demand treatment in persons with severe haemophilia

    Trakymiene, S. S. & Katarina Steen Carlsson, 2014, In : European Journal of Haematology. 93, p. 39-47

    Research output: Contribution to journalReview article

  44. Outcome measures in haemophilia: a systematic review

    Boehlen, F., Graf, L. & Erik Berntorp, 2014, In : European Journal of Haematology. 93, p. 2-15

    Research output: Contribution to journalReview article

  45. Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

    Giagounidis, A., Mufti, G. J., Mittelman, M., Sanz, G., Platzbecker, U., Muus, P., Selleslag, D., Beyne-Rauzy, O., te Boekhorst, P., del Canizo, C., Guerci-Bresler, A., Nilsson, L., Luebbert, M., Quesnel, B., Ganser, A., Bowen, D., Schlegelberger, B., Goehring, G., Fu, T., Benettaib, B. & 2 othersHellstrom-Lindberg, E. & Fenaux, P., 2014, In : European Journal of Haematology. 93, 5, p. 429-438

    Research output: Contribution to journalArticle

  46. Perinatal aspects of haemophilia

    Economou, M., Banov, L. & Rolf Ljung, 2014, In : European Journal of Haematology. 93, p. 21-25

    Research output: Contribution to journalReview article

  47. 2013
  48. Outcome of poor response paediatric AML using early SCT

    Wareham, N. E., Heilmann, C., Abrahamsson, J., Forestier, E., Gustafsson, B., Ha, S-Y., Heldrup, J., Jahnukainen, K., Jonsson, O. G., Lausen, B., Palle, J., Zeller, B. & Hasle, H., 2013, In : European Journal of Haematology. 90, 3, p. 187-194

    Research output: Contribution to journalArticle

  49. 2012
  50. Angptl4 maintains in vivo repopulation capacity of CD34(+) human cord blood cells.

    Blank Savukinas, U., Ehrnström, B., Heinz, N., Nilsson, E. C., Brun, A., Baum, C., Schiedlmeier, B. & Stefan Karlsson, 2012, In : European Journal of Haematology. 89, 3, p. 198-205

    Research output: Contribution to journalArticle

  51. High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy

    Riihijarvi, S., Nurmi, H., Holte, H., Bjorkholm, M., Fluge, O., Pedersen, L. M., Fjordén, K., Mats Jerkeman, Mikael Eriksson & Leppa, S., 2012, In : European Journal of Haematology. 89, 5, p. 395-402

    Research output: Contribution to journalArticle

Previous 1 2 3 Next